Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Scientific Reports, 2021
Accelerated inflammatory aging in Alzheimer’s disease and its relation to amyloid, tau, and cognition

Cullen N., Mälarstig A., Stomrud E. et al.

Olink Target 96NeurologyPathophysiologyPlasmaCSF

Cell Systems, 2021
Proteome-wide Systems Genetics to Identify Functional Regulators of Complex Traits

Molendijk J., Parker B.

Wider Proteomics StudiesReview/editorial

Scientific Reports, 2021
Role of PAI-1 in hepatic steatosis and dyslipidemia

Levine J., Oleaga C., Eren M. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

Biomedicines, 2021
Splenectomy Prior to Experimental Induction of Autoimmune Hepatitis Promotes More Severe Hepatic Inflammation, Production of IL-17 and Apoptosis

Buitrago-Molina L., Dywicki J., Noyan F. et al.

Olink Target 96 MouseImmunological & Inflammatory DiseasesPathophysiologySerum

Journal of Fungi, 2020
Polymorphisms within the TNFSF4 and MAPKAPK2 Loci Influence the Risk of Developing Invasive Aspergillosis: A Two-Stage Case Control Study in the Context of the aspBIOmics Consortium

Sánchez-Maldonado J., Moñiz-Díez A., ter Horst R. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasmaSerum

Nature Reviews Cardiology, 2020
Systems biology in cardiovascular disease: a multiomics approach

Joshi A., Rienks M., Theofilatos K. et al.

CVDReview/editorial

PLOS ONE, 2020
Missing value imputation in proximity extension assay-based targeted proteomics data

Lenz M., Schulz A., Koeck T. et al.

Olink Target 96Technical StudiesTechnical EvaluationPlasma

International Immunopharmacology, 2020
Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients

Eltahir M., Fletcher E., Dynesius L. et al.

Olink Target 96OncologyPathophysiologyPlasma

International Journal of Molecular Sciences, 2020
Analysis of Cerebrospinal Fluid Extracellular Vesicles by Proximity Extension Assay: A Comparative Study of Four Isolation Kits

Sjoqvist S., Otake K., Hirozane Y.

Olink Target 96NeurologyTechnical EvaluationEV Lysate

Journal of Proteome Research, 2020
Multiplatform Approach for Plasma Proteomics: Complementarity of Olink Proximity Extension Assay Technology to Mass Spectrometry-Based Protein Profiling

Petrera A., von Toerne C., Behler J. et al.

Wider Proteomics StudiesTechnology Evaluation

Journal of Clinical Immunology, 2020
Targeted Proteomics Reveals Inflammatory Pathways that Classify Immune Dysregulation in Common Variable Immunodeficiency

Berbers R., Drylewicz J., Ellerbroek P. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum

European Journal of Internal Medicine, 2020
Prevalence, risk factors and proteomic bioprofiles associated with heart failure in rheumatoid arthritis: The RA-HF study

Ferreira M., Fonseca T., Costa R. et al.

Olink Target 96Immunological & Inflammatory DiseasesCVDPathophysiologyPlasma

Scientific Reports, 2020
Expression of CARD8 in human atherosclerosis and its regulation of inflammatory proteins in human endothelial cells

Paramel G., Karadimou G., Eremo A. et al.

Olink Target 96CVDPathophysiologyCell Culture SupernatantCell Lysate

Scientific Reports, 2020
Using proximity extension proteomics assay to identify biomarkers associated with infarct size and ejection fraction after ST-elevation myocardial infarction

Mohammad M., Koul S., Egerstedt A. et al.

Olink Target 96CVDPatient StratificationPlasma

Neurology, 2020
Neurofilament Light Chain as a Biomarker of Hereditary Transthyretin-Mediated Amyloidosis

Ticau S., Sridharan G., Tsour S. et al.

Olink Target 96NeurologyPatient StratificationPlasma

Scientific Reports, 2020
Longitudinal plasma inflammatory proteome profiling during pregnancy in the Born into Life study

Hedman A., Lundholm C., Andolf E. et al.

Olink Target 96Immunological & Inflammatory DiseasesObstetricsPathophysiologyPlasma

PLOS ONE, 2020
A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients

Leandersson P., Åkesson A., Hedenfalk I. et al.

Olink Target 96OncologyPatient StratificationPlasma

Nature Metabolism, 2020
Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

Folkersen L., Gustafsson S., Wang Q. et al.

Olink Target 96Wider Proteomics StudiesCVDPathophysiologyPlasma

Angiogenesis, 2020
Microvascular dysfunction in COVID-19: the MYSTIC study

Rovas A., Osiaevi I., Buscher K. et al.

Olink Target 96CVDInfectious DiseasesPathophysiologyPlasma

Nutrients, 2020
Identification of Inflammatory and Disease-Associated Plasma Proteins that Associate with Intake of Added Sugar and Sugar-Sweetened Beverages and Their Role in Type 2 Diabetes Risk

Ramne S., Drake I., Ericson U. et al.

Olink Target 96Metabolic DiseasesPathophysiologyPlasma

2821 publications